PCCA Achieves USP Verification for Compounding Excellence
PCCA Achieves Industry First with USP Verified Excipients
PCCA, a renowned name in the pharmaceutical ingredient supply sector, has made a remarkable stride by becoming the first supplier to earn U.S. Pharmacopeia (USP) verification for two of its proprietary compounding bases: LoxOral® and Anhydrous SuspendIt®. This verification signifies a gold standard in quality assurance, affirming PCCA’s dedication to excellence in compounding.
The Significance of USP Verification
The USP Ingredient Verification Program for Excipients is a rigorous third-party assessment that involves stringent testing, meticulous audits of manufacturing processes, and comprehensive evaluations of quality control measures. With PCCA being the first FDA-registered supplier to complete this verification, this development showcases the company’s unwavering commitment to meeting industry standards and regulatory requirements.
Setting the Bar for Quality
The attainment of USP verification elevates PCCA’s products to a new level, providing a clear distinction that complements the already impressive functional benefits of its compounding bases. Recognized as a trusted quality benchmark, the USP verification process assures independent compounding pharmacies that the active ingredients, excipients, and related products they use meet the highest standards of quality.
PCCA’s Value Proposition
Gus Bassani, PharmD and CEO of PCCA, expressed the company’s core value of 'Quality without Compromise' as he celebrated this significant achievement. “This validation milestone demonstrates our commitment to quality, reassuring our pharmacies and patients alike,” Bassani stated. “By pursuing this independent verification, we empower our members to compound with confidence.”
Innovative Compounding Bases
The two USP verified bases, LoxOral® and Anhydrous SuspendIt®, are highly utilized in compounding. LoxOral® is designed as an all-in-one compounding excipient that facilitates the seamless combination of various active pharmaceutical ingredients for oral capsules. Anhydrous SuspendIt®, on the other hand, is a unique water-free oral base that effortlessly blends with liquids, improving taste and expanding its usability.
Investment in Research and Development
PCCA’s focus extends beyond mere compliance; the company is committed to enhancing therapeutic outcomes through substantial investments in research and development. This dedication enables PCCA to create novel, patented bases that not only meet industry standards but also elevate the overall quality of compounding.
Future Plans and Commitment
Looking ahead, Bassani revealed plans to pursue USP verification for more proprietary bases, showcasing the company’s proactive approach towards quality assurance even ahead of regulatory requirements. This commitment situates PCCA as a leader in delivering exceptional products to independent compounding pharmacies and health systems.
Expert Insights from USP
Holly Chang, Vice President of Technical Services at USP, voiced her support for PCCA's achievement, stating that the successful completion of the Ingredient Verification Program underscores a commitment to quality. Manufacturers of compounded pharmaceutical products can confidently recognize PCCA’s LoxOral® and Anhydrous SuspendIt® as reliable quality excipients.
About PCCA
PCCA has been a critical player in the realm of personalized medicine since its establishment in 1981. With more than 40 years of experience, the organization supports over 3,000 pharmacy members globally, providing high-quality products, educational resources, and expert support. The focus on innovation and quality assurance makes PCCA an indispensable resource for independent compounding pharmacies dedicated to improving patient outcomes. Learn more at pccarx.com.
Frequently Asked Questions
What is USP verification?
USP verification is a rigorous third-party process that assesses the quality of pharmaceutical ingredients, ensuring they meet high industry standards.
What products are USP verified by PCCA?
PCCA’s LoxOral® and Anhydrous SuspendIt® compounding bases have received USP verification.
What does PCCA specialize in?
PCCA specializes in pharmaceutical ingredients and offers tailored solutions for independent compounding pharmacies.
How does USP verification benefit pharmacies?
It assures pharmacies of the quality, purity, and consistency of the compounding bases they use, enhancing their products' reliability.
What future plans does PCCA have regarding USP verification?
PCCA intends to pursue USP verification for additional proprietary bases to further assure pharmacists and patients of product quality.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
